Dividend Champion, Contender, And Challenger Highlights: Week September 27
Danaher Corp DHR
$224.49
▲ +0.32%
(+$0.72)
Index member:
S&P 500
Open
$223.37
Prev Close
$223.77
Day Range
$221.60 – $224.90
52W Range
$160.93 – $242.80
Market Cap
$157.31B
P/E (TTM)
39.35
Beta
0.79
Div Yield
0.49%
EPS (TTM)
$5.63
📋 Company Profile
| Industry | Life Sciences Tools & Services |
| Sector | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1969-12-10 |
| Shares Out. | 702,990,000 |
| Website | danaher.com/ ↗ |
| Phone | 18667611444 |
| Employees | 60,000 |
| Revenue | $6.27B |
| Gross Profit | $3.61B |
| Net Income | $870.0M |
| Free Cash Flow | $5.47B |
| Total Assets | $92.37B |
| Total Liabilities | $39.78B |
| Equity | $52.59B |
About Danaher Corp
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Danaher Corp is a publicly traded company under the ticker symbol DHR on the NEW YORK STOCK EXCHANGE, INC., operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
32 analysts (2026-09-01)
📰 Latest News for DHR
TDM Reagent Kit Market Forecasts Growth from $2.87B (2026) to $6.96B by 2032, Profiling Abbott, Roche, Danaher, Siemens Healthineers & Thermo Fisher
Danaher Isn't Anything Special, Even After Absorbing Masimo
Danaher (DHR) Stock Looks Reasonable On Label Free Detection Growth
MaxCyte Appoints Sidharth Kapileshwar as Chief Corporate Development Officer
Global Pharmaceutical Filtration Report: Biologics Manufacturing Shifts as Danaher, Merck KGaA, Sartorius, 3M and Thermo Fisher Reshape the Market
Bioreactors Market Outlook 2026-2035 - Featuring Profiles of 3 Leading Companies: Sartorius, Thermo Fisher Scientific, and Danaher
Danaher Schedules Third Quarter 2026 Earnings Conference Call

